MedTrace Logo

Electrical Stimulation With Interferential Current in the Non-especific Chronic Low Back Pain: Effects on the Autonomic Nervous System.

NCT04483128 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2021-07-02

No results posted yet for this study

Summary

The aim of this study it's to analyze the relationship between autonomic nervous system balance (ANSb) and chronic pain conditions, especially in this case, non-especific chronic low back pain (CLBP).

Most of physiotherapy approaches focus only in biomechanical aspects, leaving aside what kind of factors could perpetuate CLBP. Since 1985, ANSb was studied due to its potential contribution to chronic pain.

Electrical stimulation, through interferential currents (IFC), it's a safe and well-known therapy used in CLBP with good outcomes regarding pain relief.

The main objective of this study it's to quantify the association between CLBP and ANSb alterations. In second place, the research team aims to record the influence of IFC over pain and ANSb in those subjects.

Conditions

Interventions

DEVICE

Electrical stimulation: Interferential Current (IFC): Experimental Group

Application of IFC with Sonopuls 692® (Enraf-Nonius BV, Rotterdam, The Netherlands) device. Parameters: 1. Carrier frequency of 4000 Hz 2. Amplitude modulated frequency of 65 Hz (AMF) 3. Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique. 4. Intensity will depend on subjet's tolerance but without generate visible muscle twitches. 5. Session duration: 25 minutes

DEVICE

Electrical stimulation: Interferential Current (IFC): Control Group

Application of IFC with Sonopuls 692® (Enraf-Nonius BV, Rotterdam, The Netherlands) device. Parameters: 1. Carrier frequency of 4000 Hz 2. Amplitude modulated frequency of 65 Hz (AMF) 3. Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique. 4. NO intensity (0 mA) 5. Session duration: 25 minutes

Sponsors & Collaborators

  • University of Seville

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-11-01
Completion
2020-12-10

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04483128 on ClinicalTrials.gov